Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Show Display Options
Rank Status Study
1 Active, not recruiting Isotretinoin for Proliferative Vitreoretinopathy
Condition: Proliferative Vitreoretinopathy
Intervention: Drug: Isotretinoin
2 Completed Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments
Conditions: Retinal Detachment;   Vitrectomy;   Proliferative Vitreoretinopathy;   Diabetic Retinopathy
Interventions: Procedure: 1000 centistoke silicone oil;   Procedure: 5000 centistoke silicone oil
3 Completed Triamcinolone Acetonide in Silicone-Filled Eyes as Adjunctive Treatment for Proliferative Vitreoretinopathy
Condition: Proliferative Vitreoretinopathy
Intervention: Drug: Triamcinolone acetonide
4 Unknown  Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)
Condition: Proliferative Vitreoretinopathy
Interventions: Drug: oral colchicine, dexamethasone, low molecular weight heparin, 5-FU;   Drug: placebo
5 Not yet recruiting Bevacizumab Against Recurrent Retinal Detachment
Conditions: Retinal Detachment;   Proliferative Vitreoretinopathy
Intervention: Drug: Bevacizumab
6 Unknown  The Effect of 5-FU and LMW Heparin on the Rate of Retinal Redetachment After Silicone Oil Removal in Cases of PVR
Condition: Proliferative Vitreoretinopathy
Intervention: Drug: low molecular weight heparin, 5-FU
7 Completed The Silicone Study
Conditions: Proliferative Vitreoretinopathy;   Retinal Detachment
Interventions: Drug: Perfluoropropane;   Drug: Sulfur Hexafluoride;   Drug: Silicone Oil
8 Recruiting Postoperative Pain Control Following Vitreoretinal Surgery
Conditions: Retinal Detachment;   Proliferative Vitreoretinopathy;   Retinoschisis
Interventions: Drug: Triamcinolone;   Drug: Bupivicaine Hydrochloride
9 Unknown  Efficacy of Oral Colchicine in Prevention of Proliferative Vitreoretinopathy in Rhegmatogenous Retinal Detachment
Condition: Rhegmatogenous Retinal Detachment
Intervention: Drug: colchicine
10 Active, not recruiting Eye Injections of Bevacizumab to See if Medication Helps to Lower Risk of Scar Tissue Development in the Retina and Repeated Retinal Detachment.
Conditions: Retinal Detachment;   Vitreoretinopathy Proliferative
Intervention: Drug: Bevacizumab
11 Unknown  Comparison High-Density Silicone Oils in Retinal Detachment
Condition: Retinal Detachment
Interventions: Drug: Oxane HD [oil-RMN3-mixture];   Drug: Densiron [(F6H8)
12 Unknown  Surgical Management of Pseudophakic and Aphakic Retinal Detachment; a Randomized Clinical Trial
Conditions: Pseudophakic Retinal Detachment;   Aphakic Retinal Detachment
Intervention: Procedure: scleral buckling, primary vitrectomy

Indicates status has not been verified in more than two years